Dexmedetomidine Hydrochloride Injection, Solution
Product Images NDC 57664-596

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine Hydrochloride (NDC 57664-596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceuticals Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Dexmedetomidine 1)

FDA Label Image

Principal Display Panel-label (Dexmedetomidine 2)

This is a 2mL single dose vial of Dexmedetomidine Hydrochloride Injection, with a strength of 200 mcg/2mL (100 meg/mL), indicated for intravenous infusion. The label states that it must be diluted and any unused portion discarded. The product is distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Gland Pharma Limited in India. The label includes a lot number and revision date, as well as an expiration date in an unvarnished area.*

FDA Label Image

Principal Display Panel-carton Label (Dexmedetomidine 3)

The text contains a mixture of useful information and garbled text. It seems to describe details related to a partition that is honeycomb type and made of Cyber XL Board. The dimensions are given as L 88, W 88, H 3321 mm, and the partition is meant to pack 25 vials. There is another section about a "Dexmedetomidine Hydrochloride Injection" that comes in 200 mg/2 mL dosage and contains no additives or chemical stabilizers. The pH range is 4.5 to 7.0. Therefore, the text provides some specific information on a partition and an injection, but it is difficult to understand the whole text due to errors.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.